The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

The Emmy nominee also created Sherri Shepherd's sitcom and worked on 'Ellen,' 'The PJs,' 'Boardwalk Empire' and more.

Merck to acquire respiratory drug maker, Verona Pharma for $10 billion: Rahway, New Jersey Thursday, July 10, 2025, 09:00 Hrs [IST] Merck, known as MSD outside of the United State ...

BiomX has published promising phase 1b/2a trial results in Nature Communications, demonstrating that its phage cocktail BX004 ...

Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.

The genetic disorder cystic fibrosis is unique because it can cause both breathing and digestive problems.Some 40,000 people ...

Merck said the deal is valued at $107 per ADS, a 23% premium to Verona’s closing price yesterday.

Premier research journal article provides validation for BiomX’s phage therapy platform, showcasing first-in-human Phase ...

At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...

Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome (communities of bacteria) of infants with cystic fibrosis (CF) compared to ...

Cystic fibrosis is a chronic, progressive, life-threatening disease. It’s caused by a mutation on chromosome seven. This mutation leads to abnormalities in or the absence of a certain protein.